HDAC9 and cancer: To investigate the anti-cancer activity of HNHA alongside two well-known HDAC inhibitors (TSA and SAHA), we assayed ATC (SNU-80) and PTC (SNU-790) cell proliferation in the presence and absence of these compounds using an MTT assay (Table 1).